Form 4: Beam Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Amy Simon, Chief Medical Officer of Beam Therapeutics Inc., sold 16,667 shares of common stock on July 27, 2026 for $25.74 per share.
Summary
- Open-market sale: disposed of 16,667 Common Stock at $25.74 ($429,037) on July 27, 2026; holds 85,696 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $429,037 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Amy Simon — Officer (Chief Medical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Open-market sale | Common Stock | 16,667 | $26 | $429.0K | 85,696 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Open-market sale (16,667 shares) |
Keywords
insider transaction, Form 4, BEAM, Beam Therapeutics Inc., bearish, Amy Simon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.